Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Marlborough Pharmaceuticals Ltd, Sovereign House, Miles Gray Road, Basildon, Essex SS14 3FR, UK
SINEPIN 25mg Capsules.
Doxepin 25mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsules. Dark blue cap and orange body, opaque, size 3 hard gelatin capsules. |
Active Ingredient: Doxepin Hydrochloride BP.
The capsules contain Doxepin Hydrochloride BP equivalent to 25mg doxepin.
Excipient(s) with known effect: Each capsule also contains 130.00 mg of lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Doxepin |
Doxepin is not a central nervous system stimulant nor a monoamine oxidase inhibitor. The current hypothesis is that the clinical effects are due, at least in part, to influences on the adrenergic activity at the synapses so that deactivation of noradrenaline by reuptake into the nerve terminals is prevented. |
| List of Excipients |
|---|
|
Doxepin 25mg Capsule: Lactose Capsule shell constituents: Amaranth (E123) Doxepin 25mg Capsules are free of gluten and sucrose. |
Doxepin 25mg Capsules are available as: Packs of 28 capsules. Aluminium/PVC blister strips; 2 rows of 7 capsules per strip, 2 strips in a carton box.
Marlborough Pharmaceuticals Ltd, Sovereign House, Miles Gray Road, Basildon, Essex SS14 3FR, UK
PL 23138/0002
September 2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
